Douglas B. Snyder is CLO at GW PHARMACEUTICALS PLC (GWPH). They have made 11 open-market trades across 1 company since 2019, most recently 2025-11-28.
CIK 0001754125
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GWPH | SELL | 2021-03-26 | 2021-04-08 | $18.12 | $152K | +0.4% | N/A | N/A |
| GWPH | SELL | 2020-12-07 | 2020-12-09 | $11.01 | $456K | -0.1% | +5.5% | +77.2% |
| GWPH | SELL | 2020-09-30 | 2020-10-02 | $8.13 | $234K | +1.1% | -7.0% | +20.2% |
| GWPH | SELL | 2020-08-11 | 2020-08-12 | $9.40 | $226K | -1.9% | -5.5% | +7.5% |
| GWPH | SELL | 2020-07-06 | 2020-07-08 | $10.50 | $103K | +6.9% | -15.9% | -26.0% |
| GWPH | SELL | 2020-03-02 | 2020-03-04 | $8.32 | $21K | -28.2% | -18.9% | +26.2% |
| GWPH | SELL | 2020-02-26 | 2020-02-28 | $9.17 | $36K | -15.1% | -16.8% | +22.5% |
| GWPH | SELL | 2019-08-19 | 2019-08-21 | $13.04 | $141K | -6.3% | -15.5% | -32.1% |
| GWPH | SELL | 2019-08-12 | 2019-08-14 | $13.88 | $104K | -10.0% | -9.5% | -29.8% |
| GWPH | SELL | 2019-07-09 | 2019-07-11 | $14.42 | $143K | -7.1% | -8.2% | -36.2% |
| GWPH | SELL | 2019-02-26 | 2019-02-28 | $12.43 | $58K | -1.4% | -3.1% | +4.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.